| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Qin,Jia-Qi | Chairman | 10.85% | |
| Chen,You-Liang | Director | 2.64% | |
| Ye,Pei-Cheng | Director | 7.25% | XI WEI INVESTMENT CO., LTD. |
| Lin,Pei-Pei | Director | 10.18% | JUN YUE INVESTMENT CO., LTD. |
| Wu,Jia-Rong | Independent Director | 0.00% | |
| Wu,Yi-Ying | Independent Director | 0.00% | |
| Chen,Shu-Zi | Independent Director | 0.00% |
Change Person in Charge to Qin,Jia-Qi
2022/12/08
Change Capital to 3,000,000,000
2020/04/16
Change Person in Charge to Chen,You-Liang
2018/10/11
Change Person in Charge to Xu,Zong-Xian
2013/07/15
Change Capital to 2,200,000,000
2011/07/11
Change Capital to 2,500,000,000
2011/05/20
Change Person in Charge to Huang,Jun-Liang
2011/05/20
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 66,498 | 673,273 | 1,342,715 |
| Operating cost | 60,788 | 535,513 | 1,104,293 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 5,710 | 137,760 | 238,422 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 5,710 | 137,760 | 238,422 |
| Operating expenses | 109,223 | 405,369 | 428,260 |
| Other gain (loss), net | 0 | -141 | -1,559 |
| Operating profit (loss) | -103,513 | -267,750 | -191,397 |
| Non-operating income and expenses | 22,477 | -23,445 | 146,386 |
| Net profit (loss) before tax | -81,036 | -291,195 | -45,011 |
| Income tax expense (benefits) | -1,038 | -15,297 | 10,221 |
| Net profit (loss) of ongoing business for the current period | -79,998 | -275,898 | -55,232 |
| Profit (loss) of closed units | 0 | - | 0 |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -79,998 | -275,898 | -55,232 |
| Other comprehensive profit (loss), net | 3,567 | 16,484 | 35,021 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -76,431 | -259,414 | -20,211 |
| Net profit (loss) attributable to owners of parent company | -74,708 | -251,519 | -56,085 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -5,290 | -24,379 | 853 |
| Comprehensive profit (loss) attributable to owners of parent company | -71,141 | -235,035 | -21,320 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -5,290 | -24,379 | 1,109 |
| Basic earnings per share (yuan) | 0 | -2 | 0 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -39,889 | -208,675 | 137,857 |
| Net cash inflows (outflows) from investing activities | -47,598 | 551,440 | 615,000 |
| Net cash inflow (outflow) from financing activities | 24,677 | -574,125 | -396,007 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 26,012 | 41,757 | 971 |
| Increase (decrease) in cash and cash equivalents in the current period | -36,798 | -189,603 | 357,821 |
| Beginning balance of cash and cash equivalents | 1,271,021 | 1,460,624 | 1,102,803 |
| Ending balance of cash and cash equivalents | 1,234,223 | 1,271,021 | 1,460,624 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 1,660,825 | 1,781,054 | 2,834,902 |
| Non-current asset | 849,729 | 811,212 | 789,302 |
| Total asset | 2,510,554 | 2,592,266 | 3,624,204 |
| Current liability | 244,900 | 317,496 | 800,479 |
| Non-current liability | 148,652 | 147,423 | 226,697 |
| Total liability | 393,552 | 464,919 | 1,027,176 |
| share capital | 1,149,749 | 1,149,749 | 1,149,749 |
| Equity - secruity token | - | - | - |
| capital reserve | 393,094 | 390,640 | 437,109 |
| retained earning | 710,111 | 784,819 | 1,102,379 |
| Other equity | -115,323 | -118,890 | -133,050 |
| Treasury stock | -59,164 | -127,617 | -38,174 |
| Total equity attributable to owners of parent company | 2,078,467 | 2,078,701 | 2,518,013 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 38,535 | 48,646 | 79,015 |
| Total Equity | 2,117,002 | 2,127,347 | 2,597,028 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 952,030 | 2,246,030 | 906,030 |
| Net asset value per share | 18 | 18 | 22 |
| 標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
|---|---|---|---|---|
| 邏輯分析儀系統等2項 | 國防部軍備局中山科學研究院 | 102/04/03 | 否 |
Others
2002
Pay remuneration
2006
Time-limited prosecution
2008
Confirmation of the existence of employment relationship, etc
2012, 2013
Confirmation that the resolution of the shareholders' meeting is invalid, etc.
2018
Others
2002, 2022
Return deposit
2009
Pay remuneration
2017
Petition for trial
2019
Compensation for damage
2011, 2012, 2014, 2016
Pay for liquidated damages
2002, 2003
Profit-seeking Enterprise Income Tax
2013, 2014
Peition for determination of legal expenses
2014
Petition for Approval of Attorney's Remuneration
2014
